DK1571970T3 - Diagnose og monitorering af sygdomme - Google Patents
Diagnose og monitorering af sygdommeInfo
- Publication number
- DK1571970T3 DK1571970T3 DK03773099.1T DK03773099T DK1571970T3 DK 1571970 T3 DK1571970 T3 DK 1571970T3 DK 03773099 T DK03773099 T DK 03773099T DK 1571970 T3 DK1571970 T3 DK 1571970T3
- Authority
- DK
- Denmark
- Prior art keywords
- monitoring
- diseases
- diagnosis
- disease
- amino acids
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41590802P | 2002-10-02 | 2002-10-02 | |
US48903903P | 2003-07-21 | 2003-07-21 | |
US50318503P | 2003-09-15 | 2003-09-15 | |
PCT/US2003/031226 WO2004030522A2 (en) | 2002-10-02 | 2003-10-02 | Diagnosis and monitoring of diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1571970T3 true DK1571970T3 (da) | 2011-11-28 |
Family
ID=32074376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03773099.1T DK1571970T3 (da) | 2002-10-02 | 2003-10-02 | Diagnose og monitorering af sygdomme |
Country Status (9)
Country | Link |
---|---|
US (2) | US7575929B2 (da) |
EP (1) | EP1571970B1 (da) |
JP (1) | JP4674317B2 (da) |
AT (1) | ATE520981T1 (da) |
AU (1) | AU2003279761B2 (da) |
CA (1) | CA2500652A1 (da) |
DK (1) | DK1571970T3 (da) |
NZ (1) | NZ539735A (da) |
WO (1) | WO2004030522A2 (da) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7070937B1 (en) | 1998-10-02 | 2006-07-04 | Ischemia Technologies, Inc. | Marker useful for detection and measurement of free radical damage and method |
US6475743B1 (en) | 1998-10-02 | 2002-11-05 | Ischemia Technologies, Inc. | Marker useful for detection and measurement of free radical damage and method |
US20030215952A1 (en) * | 1998-10-02 | 2003-11-20 | Ischemia Technologies, Inc. | Tests for the rapid evaluation of ischemic states and kits |
US20050142613A1 (en) * | 1998-10-02 | 2005-06-30 | David Bar-Or | Test for the rapid evaluation of ischemic states and kits |
US7449338B2 (en) | 1998-10-02 | 2008-11-11 | Ischemia Technologies, Inc. | Tests for the rapid evaluation of ischemic states and kits |
JP5048201B2 (ja) | 2000-08-04 | 2012-10-17 | ディーエムアイ バイオサイエンシズ インコーポレイテッド | ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物 |
ES2572975T3 (es) * | 2003-05-15 | 2016-06-03 | Ampio Pharmaceuticals, Inc. | Tratamiento de enfermedades mediadas por los linfocitos T |
GB0421639D0 (en) * | 2004-09-29 | 2004-10-27 | Proteome Sciences Plc | Methods and compositions relating to alzheimer's disease |
AU2006223068A1 (en) | 2005-03-14 | 2006-09-21 | Bg Medicine, Inc. | Methods for detecting Alzheimer's disease |
WO2006110621A2 (en) * | 2005-04-11 | 2006-10-19 | Cornell Research Foundation, Inc. | Multiplexed biomarkers for monitoring the alzheimer's disease state of a subject |
JP5496650B2 (ja) * | 2006-03-21 | 2014-05-21 | メタボロン インコーポレイテッド | サンプル内の個々の要素を識別及び定量化するために分光測定データを分析するシステム、方法及びコンピュータプログラム製品 |
WO2008141285A2 (en) * | 2007-05-11 | 2008-11-20 | The Institutes For Pharmaceutical Discovery, Llc | Methods for early diagnosis of kidney disease |
US7829709B1 (en) | 2007-08-10 | 2010-11-09 | Marquette University | Cysteine prodrugs to treat schizophrenia and drug addiction |
ES2663662T3 (es) | 2008-01-18 | 2018-04-16 | President And Fellows Of Harvard College | Métodos para detectar distintivos de enfermedades o afecciones en fluidos corporales |
EP2252596B1 (en) | 2008-02-07 | 2016-12-28 | Marquette University | Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
JP5856843B2 (ja) | 2008-05-27 | 2016-02-10 | アンピオ ファーマシューティカルズ,インコーポレイテッド | ジケトピペラジンを用いた医薬組成物 |
CN102574818B (zh) * | 2009-07-30 | 2015-02-25 | 萨尔瓦特实验室股份有限公司 | Apaf-1抑制剂化合物 |
CA2806310A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting diseases or conditions using phagocytic cells |
WO2012012704A2 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting kidney-associated diseases or conditions |
AU2011280936A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
SG10201505723UA (en) | 2010-07-23 | 2015-09-29 | Harvard College | Methods for detecting signatures of disease or conditions in bodily fluids |
US20130184178A1 (en) | 2010-07-23 | 2013-07-18 | President And Fellows Of Harvard College | Methods of Detecting Autoimmune or Immune-Related Diseases or Conditions |
EP2613786A4 (en) | 2010-09-07 | 2013-10-23 | Dmi Acquisition Corp | TREATMENT OF DISEASES |
WO2012035871A1 (ja) * | 2010-09-16 | 2012-03-22 | カルピス株式会社 | 脳機能改善用組成物および脳機能を改善する方法 |
AU2012312452A1 (en) | 2011-09-19 | 2014-04-10 | C2N Diagnostics | Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes |
KR102032400B1 (ko) | 2011-10-10 | 2019-10-15 | 앰피오 파마슈티컬스 인코퍼레이티드 | 퇴행성 관절 질환의 치료 |
WO2013055749A1 (en) | 2011-10-10 | 2013-04-18 | Ampio Pharmaceuticals, Inc. | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
SG10201605205VA (en) * | 2011-10-28 | 2016-08-30 | Ampio Pharmaceuticals Inc | Treatment of rhinitis |
US10494675B2 (en) | 2013-03-09 | 2019-12-03 | Cell Mdx, Llc | Methods of detecting cancer |
EP2965086A4 (en) | 2013-03-09 | 2017-02-08 | Harry Stylli | Methods of detecting prostate cancer |
WO2014145729A2 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
CN103604931B (zh) * | 2013-11-15 | 2016-01-06 | 陆上苏 | 一种人s100蛋白检测试剂及制备方法 |
RU2020136589A (ru) | 2014-08-18 | 2020-12-24 | Ампио Фармасьютикалз, Инк. | Лечение дегенеративных заболеваний суставов |
US10626464B2 (en) | 2014-09-11 | 2020-04-21 | Cell Mdx, Llc | Methods of detecting prostate cancer |
US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
Family Cites Families (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3928330A (en) * | 1973-12-19 | 1975-12-23 | Ciba Geigy Corp | Substituted piperazinedione carboxylic acids and metal salts thereof |
GB1459488A (en) * | 1974-03-19 | 1976-12-22 | Wyeth John & Brother Ltd | Piperazinedione derivatives |
US4205057A (en) * | 1978-01-17 | 1980-05-27 | Government Of The United States | Cerebrospinal fluid protein fragments |
DE2940654A1 (de) * | 1979-10-06 | 1981-04-16 | Bayer Ag, 5090 Leverkusen | Dimeres keten der 1,2,,-triazol-3-carbonsaeure |
US4331595A (en) * | 1980-06-23 | 1982-05-25 | Ortho Pharmaceutical Corporation | Immunoregulatory diketopiperazine compounds |
US4289759A (en) | 1980-06-23 | 1981-09-15 | Ortho Pharmaceutical Corporation | Immunoregulatory diketopiperazine compounds |
JPS5973574A (ja) | 1982-10-21 | 1984-04-25 | Grelan Pharmaceut Co Ltd | 環状ジペプチド類 |
US4694061A (en) * | 1983-10-12 | 1987-09-15 | Ciba-Geigy Corporation | Radiation-sensitive polycondensates, processes for their preparation coated material and its use |
US4806538A (en) * | 1984-11-02 | 1989-02-21 | Fujisawa Pharmaceutical Co., Ltd. | Piperazine compound as PAF-antagonist |
CS254868B1 (cs) | 1985-06-11 | 1988-02-15 | Jiri Vanzura | Způsob výroby cyklických dipeptidů |
US4661500A (en) | 1985-08-29 | 1987-04-28 | Roman Rozencwaig | Method of medical treatment with serotonin antagonists |
US4771056A (en) * | 1985-08-29 | 1988-09-13 | Roman Rozencwaig | Method of medical treatment with serotonin antagonists |
US5047401A (en) * | 1985-09-09 | 1991-09-10 | Board Of Regents, The University Of Texas System | Use of dipeptide alkyl esters to treat GVHD |
US4694081A (en) | 1985-09-23 | 1987-09-15 | Monsanto Company | Process to prepare 2,5-diketopiperazines |
US5512544A (en) * | 1987-09-13 | 1996-04-30 | Yeda Research And Development Co. Ltd. | Pharmaceutical compositions comprising an anticytokine |
US4992552A (en) * | 1988-08-31 | 1991-02-12 | Eastman Kodak Company | Process for preparation of amino acids |
DE3906952A1 (de) * | 1989-03-04 | 1990-09-06 | Boehringer Mannheim Gmbh | (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel |
EP0422282B1 (en) | 1989-10-13 | 1995-04-05 | Phobos N.V. | Process for the continuous production of high molecular weight polyester resin |
US6180616B1 (en) * | 1990-05-10 | 2001-01-30 | Atsuo F. Fukunaga | Use of purine receptor agonists to alleviate or normalize physiopathologically excited sensory nerve function |
US6331318B1 (en) * | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
US6099856A (en) * | 1992-06-15 | 2000-08-08 | Emisphere Technologies, Inc. | Active agent transport systems |
US5693338A (en) * | 1994-09-29 | 1997-12-02 | Emisphere Technologies, Inc. | Diketopiperazine-based delivery systems |
US5578323A (en) * | 1992-06-15 | 1996-11-26 | Emisphere Technologies, Inc. | Proteinoid carriers and methods for preparation and use thereof |
GB9022543D0 (en) * | 1990-10-17 | 1990-11-28 | Wellcome Found | Antibody production |
CA2095539A1 (en) | 1990-11-14 | 1992-05-15 | Robert D. Cook | Diagnosis and treatment of multiple sclerosis |
US5776892A (en) * | 1990-12-21 | 1998-07-07 | Curative Health Services, Inc. | Anti-inflammatory peptides |
JPH04234374A (ja) | 1990-12-27 | 1992-08-24 | Ajinomoto Co Inc | ジケトピペラジン誘導体の製造方法 |
US5543503A (en) * | 1991-03-29 | 1996-08-06 | Genentech Inc. | Antibodies to human IL-8 type A receptor |
US5538993A (en) * | 1991-09-12 | 1996-07-23 | Yissum Research Development Company | Certain tetrahydrocannabinol-7-oic acid derivatives |
JPH05244982A (ja) * | 1991-12-06 | 1993-09-24 | Sumitomo Chem Co Ltd | 擬人化b−b10 |
GB9200210D0 (en) | 1992-01-07 | 1992-02-26 | British Bio Technology | Compounds |
US5418218A (en) * | 1992-07-10 | 1995-05-23 | The University Of Maryland At Baltimore | Histidyl-proline diketopiperazine (cyclo his-pro) a cns-active pharmacologic agent |
US5434151A (en) * | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5358938A (en) * | 1992-07-13 | 1994-10-25 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5463083A (en) * | 1992-07-13 | 1995-10-31 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5648486A (en) * | 1992-07-13 | 1997-07-15 | Cytomed, Inc. | Compounds and methods for the treatment of inflammatory and immune disorders |
GB9217331D0 (en) * | 1992-08-14 | 1992-09-30 | Xenova Ltd | Pharmaceutical compounds |
US5728553A (en) * | 1992-09-23 | 1998-03-17 | Delta Biotechnology Limited | High purity albumin and method of producing |
RU2137131C1 (ru) * | 1992-12-18 | 1999-09-10 | Молекьюлар Ар-Экс, Инк. | Гибридная клеточная линия (варианты), препарат антител (варианты), способ диагностики рассеянного склероза у человека (варианты), способ лечения человека, полипептид |
ES2068742B1 (es) | 1993-02-11 | 1995-11-16 | Uriach & Cia Sa J | Nuevos derivados de piridinio. |
US6107050A (en) * | 1993-05-03 | 2000-08-22 | The United States Of America As Represented By The Department Of Health And Human Services | Diagnostic test for alzheimers disease |
FR2717484A1 (fr) | 1994-03-16 | 1995-09-22 | Pf Medicament | Nouveaux composés pseudo-bis-peptidiques analogues de la CCK, leur procédé de préparation, leur utilisation à titre de médicament et les compositions pharmaceutiques les comprenant . |
GB9410387D0 (en) * | 1994-05-24 | 1994-07-13 | Xenova Ltd | Pharmaceutical compounds |
US5550132A (en) * | 1994-06-22 | 1996-08-27 | University Of North Carolina | Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines |
US5990112A (en) * | 1996-06-18 | 1999-11-23 | Affymax Technologies N.V. | Inhibitors of metalloproteases pharmaceutical compositions comprising same and methods of their use |
US5817751A (en) * | 1994-06-23 | 1998-10-06 | Affymax Technologies N.V. | Method for synthesis of diketopiperazine and diketomorpholine derivatives |
US5792776A (en) * | 1994-06-27 | 1998-08-11 | Cytomed, Inc., | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5703093A (en) * | 1995-05-31 | 1997-12-30 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5750565A (en) * | 1995-05-25 | 1998-05-12 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
EP0801065A4 (en) * | 1994-07-29 | 1998-02-25 | Nikken Chemicals Co Ltd | 1,4-DIHYDROPYRIDINE COMPOUNDS AND MEDICAL COMPOSITIONS CONTAINING THEM |
PL181802B1 (en) | 1994-10-05 | 2001-09-28 | Cari Loder | Treatment of sclerosis multiplex (sm) an dother demyelination states |
AU691361B2 (en) * | 1994-12-01 | 1998-05-14 | Toyama Chemical Co. Ltd. | Novel 2,3-diketopiperazine derivative or salt thereof |
US6034057A (en) * | 1995-07-06 | 2000-03-07 | Zeneca Limited | Peptide inhibitors of fibronectine |
US6060452A (en) * | 1996-03-13 | 2000-05-09 | Cytran, Inc. | Analogs of L-Glu-L-Trp having pharmacological activity |
US6541224B2 (en) * | 1996-03-14 | 2003-04-01 | Human Genome Sciences, Inc. | Tumor necrosis factor delta polypeptides |
US5919785A (en) * | 1996-04-03 | 1999-07-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
GB2328155B (en) * | 1996-04-12 | 2000-08-02 | Peptide Technology Pty Limited | Methods of treating immunopathologies using polyunsaturated fattyacids |
DE19619478A1 (de) * | 1996-05-14 | 1997-11-20 | Sick Ag | Optische Anordnung mit diffraktivem optischem Element |
US5932579A (en) * | 1996-06-18 | 1999-08-03 | Affymax Technologies N.V. | Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use |
US5985581A (en) * | 1996-07-25 | 1999-11-16 | The Mclean Hospital Corporation | Use of presenilin-1 for diagnosis of alzheimers disease |
EP0835660A1 (en) | 1996-10-14 | 1998-04-15 | Gaston Edmond Filomena Merckx | Products containing methylcobalamin for the treatment of multiple sclerosis or other demyelinating conditions |
US6441172B1 (en) * | 1996-11-07 | 2002-08-27 | Torrey Pines Institute For Molecular Studies | Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
US6265535B1 (en) * | 1997-05-30 | 2001-07-24 | The Trustees Of The University Of Pennsylvania | Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses |
US6222029B1 (en) * | 1997-08-01 | 2001-04-24 | Genset | 5′ ESTs for secreted proteins expressed in brain |
US5834032A (en) * | 1997-08-11 | 1998-11-10 | Song; Moon K. | Compositions and methods for treating diabetes |
EP0939124A3 (en) | 1998-02-24 | 2001-03-21 | Smithkline Beecham Plc | MGBP1 sequences |
US6492179B1 (en) * | 1998-10-02 | 2002-12-10 | Ischemia Techologies, Inc. | Test for rapid evaluation of ischemic states and kit |
EP1117686B1 (en) * | 1998-10-02 | 2008-07-16 | Ischemia Technologies, Inc. | Methods and materials for detection and measurement of free radical damage |
US6475743B1 (en) * | 1998-10-02 | 2002-11-05 | Ischemia Technologies, Inc. | Marker useful for detection and measurement of free radical damage and method |
US6461875B1 (en) * | 1998-10-02 | 2002-10-08 | Ischemia Technologies, Inc. | Test for rapid evaluation of ischemic states and kit |
CA2344762C (en) * | 1998-10-02 | 2008-12-23 | Ischemia Technologies, Inc. | Tests for the rapid evaluation of ischemic states and kits |
DE19847690A1 (de) * | 1998-10-15 | 2000-04-20 | Brahms Diagnostica Gmbh | Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen |
US7026322B2 (en) * | 1998-11-12 | 2006-04-11 | Nereus Pharmaceuticals, Inc. | Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds |
US6358957B1 (en) * | 1998-11-12 | 2002-03-19 | Nereus Pharmaceuticals, Inc. | Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
EP1166117A2 (en) * | 1999-03-19 | 2002-01-02 | Vanderbilt University | Diagnosis and treatment of multiple sclerosis |
US6090780A (en) * | 1999-04-07 | 2000-07-18 | Chandon Prasad | Histidyl-proline diketopiperazine and method of use |
US6689765B2 (en) * | 1999-05-04 | 2004-02-10 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
DE19937721A1 (de) | 1999-08-10 | 2001-02-15 | Max Planck Gesellschaft | Neue Diketopiperazine |
US6677473B1 (en) * | 1999-11-19 | 2004-01-13 | Corvas International Inc | Plasminogen activator inhibitor antagonists |
US20050096323A1 (en) * | 1999-11-30 | 2005-05-05 | Novoscience Pharma Inc. | Diketopiperazine derivatives to inhibit thrombin |
US6635649B2 (en) * | 2000-05-09 | 2003-10-21 | Che-Ming Teng | Piperazinedione compounds |
US7288545B2 (en) * | 2000-05-09 | 2007-10-30 | Angiorx Corporation | Piperazinedione compounds |
JP2004533402A (ja) * | 2000-06-08 | 2004-11-04 | リリー アイコス リミテッド ライアビリティ カンパニー | Pdevインヒビターとしての四環系ジケトピペラジン化合物 |
CZ20002681A3 (cs) | 2000-07-21 | 2002-03-13 | Ev®En Ing. Csc. Kasafírek | Cyklické tyrosinové dipeptidy |
CZ20002680A3 (cs) | 2000-07-21 | 2002-03-13 | Ev®En Ing. Csc. Kasafírek | Cyklické alkylthiopeptidy |
US6967202B2 (en) * | 2000-08-04 | 2005-11-22 | Dmi Biosciences, Inc. | Method of synthesizing diketopiperazines |
JP5048201B2 (ja) * | 2000-08-04 | 2012-10-17 | ディーエムアイ バイオサイエンシズ インコーポレイテッド | ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物 |
WO2002062797A2 (en) * | 2000-12-29 | 2002-08-15 | Celltech R & D, Inc. | Pharmaceutical uses and synthesis of diketopiperazines |
US20040038865A1 (en) * | 2002-08-01 | 2004-02-26 | Mannkind Corporation | Cell transport compositions and uses thereof |
DE10238144A1 (de) * | 2002-08-15 | 2004-02-26 | Basf Ag | Verwendung von Diketopiperazin-Derivaten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen |
US7378403B2 (en) * | 2002-09-03 | 2008-05-27 | The United States Of America As Represented By The Department Of Health And Human Services | Akt inhibitors, pharmaceutical compositions, and uses thereof |
ES2572975T3 (es) * | 2003-05-15 | 2016-06-03 | Ampio Pharmaceuticals, Inc. | Tratamiento de enfermedades mediadas por los linfocitos T |
-
2003
- 2003-10-02 CA CA002500652A patent/CA2500652A1/en not_active Abandoned
- 2003-10-02 WO PCT/US2003/031226 patent/WO2004030522A2/en active Search and Examination
- 2003-10-02 DK DK03773099.1T patent/DK1571970T3/da active
- 2003-10-02 AU AU2003279761A patent/AU2003279761B2/en not_active Ceased
- 2003-10-02 AT AT03773099T patent/ATE520981T1/de not_active IP Right Cessation
- 2003-10-02 NZ NZ539735A patent/NZ539735A/en not_active IP Right Cessation
- 2003-10-02 US US10/679,699 patent/US7575929B2/en not_active Expired - Fee Related
- 2003-10-02 EP EP03773099A patent/EP1571970B1/en not_active Expired - Lifetime
- 2003-10-02 JP JP2005500360A patent/JP4674317B2/ja not_active Expired - Fee Related
-
2009
- 2009-07-07 US US12/499,063 patent/US20100120056A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004030522A3 (en) | 2005-08-11 |
CA2500652A1 (en) | 2004-04-15 |
NZ539735A (en) | 2009-07-31 |
EP1571970A4 (en) | 2008-06-04 |
JP4674317B2 (ja) | 2011-04-20 |
EP1571970A2 (en) | 2005-09-14 |
ATE520981T1 (de) | 2011-09-15 |
AU2003279761A1 (en) | 2004-04-23 |
WO2004030522A2 (en) | 2004-04-15 |
US20100120056A1 (en) | 2010-05-13 |
JP2006502418A (ja) | 2006-01-19 |
AU2003279761B2 (en) | 2009-11-12 |
EP1571970B1 (en) | 2011-08-17 |
US7575929B2 (en) | 2009-08-18 |
US20040209379A1 (en) | 2004-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1571970T3 (da) | Diagnose og monitorering af sygdomme | |
CA2395724A1 (en) | NUCLEIC ACIDS, PROTEINS AND ANTIBODIES | |
MX2007013626A (es) | Anticuerpos dirigidos contra el peptido beta amiloide y procedimientos que usan los mismos. | |
WO2005000193A3 (en) | Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases | |
WO2002090526A3 (en) | Human secreted proteins | |
IL195338A (en) | An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use | |
DK1521774T3 (da) | Trunkerede Tau-proteiner | |
EA200501017A1 (ru) | Астма и модуляторы аллергических воспалений | |
DE60332320D1 (de) | Neues screening-verfahren | |
BRPI0616712B8 (pt) | método para amidar polipeptídeos com terminais c de aminoácido básicos por meio de endoproteases específicas | |
WO2001054472A8 (en) | Nucleic acids, proteins, and antibodies | |
WO2002099085A3 (en) | Human secreted proteins | |
ATE455792T1 (de) | Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon | |
ATE360034T1 (de) | Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft | |
ATE310736T1 (de) | Verbindungen zur bilddarstellung der alzheimer- krankenheit | |
WO2002026930A3 (en) | Nucleic acids, proteins, and antibodies | |
WO2004042000A3 (en) | 157 human secreted proteins | |
DE60041582D1 (de) | Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis | |
ATE485831T1 (de) | Behandlung von neurodegeneration | |
WO2001055168A8 (en) | Nucleic acids, proteins and antibodies | |
WO2002072763A3 (en) | Nucleic acids, proteins, and antibodies | |
CA2530731A1 (en) | Peptide having apoptosis-inhibiting activity | |
BR0316740A (pt) | ácido nucléico compreendendo uma sequência codificando um polipeptìdeo de glutenina modificada | |
DE60321443D1 (de) | Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung | |
ATE511643T1 (de) | Fragment des neurosekretorischen proteins vgf als biomarker für morbus alzheimer |